IGF2BP2 and prostate carcinoma: Moreover, the measurement of the rate of RNA decay in prostate cancer cells with IGF2BP2/3 silencing and corresponding controls showed that the DDIT4 mRNA level was decreased and the mRNA half-life was significantly shortened after IGF2BP2/3 silencing in LNCaP cells (Fig. 7Q and R).